Quarterly / Interim Statement/Quarter ResultsSCHOTT Pharma records good start into fiscal year and confirms full year outlook 13.02.2025 / 07:00 CET/CESTThe issuer is solely responsible for the ...
JERSEY CITY, NJ, USA I January 30, 2025 I Celltrion today announced that the U.S. Food and Drug Administration (FDA) has approved AVTOZMA® (CT-P47, ...
The Food and Drug Administration (FDA) has approved Avtozma ® (tocilizumab-anoh), a biosimilar to Actemra ® (tocilizumab), in both intravenous (IV) and subcutaneous (SC) formulations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback